Purchase Order 75N95A24P00086
- Not listed
- Rutgers, The State University of New Jersey was awarded a $2.5 million firm fixed-price delivery order against the National Institutes of Health National Institute on Drug Abuse's Center for Genetic Studies indefinite delivery/indefinite quantity contract. Under the one-year task order, Rutgers will provide research services in support of NIDA's mission to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health....
- The National Institute on Drug Abuse (NIDA) Center for Genetic Studies awarded a $2.5 million firm fixed price delivery order contract to Rutgers, The State University Research Financial Services Division for the period of March 14, 2022 through March 13, 2023. As the prime contractor, Rutgers, The State University Research Financial Services Division will provide research services in support of NIDA's Center for Genetic Studies, with performance taking place in New Brunswick, New Jersey.
- This is a $1,647,593 firm-fixed-price delivery order awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Rutgers, The State University of New Jersey. The award is for the NIDA Center for Genetic Studies, where Rutgers will receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts over a 5-year period from March 2023 to March 2028. This delivery order provides $1.6 million...
- This is a firm-fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), an agency within the Department of Health and Human Services, to Rutgers, The State University of New Jersey. The contract, valued at $1,982,526.92, is for the NIDA Adolescent Brain Cognitive Development (ABCD) Study Genome Center and Biospecimens Repository. Rutgers, through its Research Financial Services Division, will receive, process, store, and distribute de-identified clinical data and...
- Rutgers, The State University has been awarded a task order against an existing National Institute on Drug Abuse (NIDA) indefinite delivery contract to establish and operate the NIDA Center for Genetic Studies. The task order, valued at $2,716,366, provides continued genetic research services for the Center between March 2023 and March 2024. Specifically, Rutgers will receive, process, store and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants...
- This is a $16,252,811.88 definitive contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Rutgers, The State University for biomedical research and development services. The contract has a firm fixed price pricing type and a period of performance through July 13, 2013. Rutgers, a major public research institution, will provide applied and exploratory biomedical research under this contract, which supports the NIDDK Genetics Repository program. This...
- This is a delivery order under a $15 million Indefinite Delivery Contract (IDC) awarded by the National Institute on Drug Abuse (NIDA) to Rutgers, The State University. The task order, valued at $2,807,643, is for the NIDA Center for Genetic Studies, which Rutgers operates to receive, process, store, and distribute de-identified clinical data and biospecimens from NIDA-funded addiction research grants and contracts. This supports NIDA's research objectives on genetic factors related to substance...
- This federal contract award was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the U.S. Department of Health and Human Services. The $300,216 Firm Fixed Price contract was awarded to Rutgers, The State University to support "Computational Thinking to Support Clinicians and Biomedical Scientists". This work was funded through the American Recovery and Reinvestment Act (ARRA). The contract does not have a set-aside designation....
- This contract award is for the NIDA Center for Genetic Studies, which is a single-award Indefinite Delivery Contract from the National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services National Institutes of Health. The prime contractor is Rutgers, The State University, through its Research Financial Services Division. The contract is for the establishment and operation of the NIDA Center for Genetic Studies, which involves receiving, processing, storing and...
- This federal contract award with ID 80NSSC24K0570 was granted to Rutgers, The State University through its Research Financial Services Division, a major public research institution. The $499,939 grant is for a research project titled "EMBRACING THE 3D ERA EXPLORING VERTICAL ACCLIMATION OF VEGETATION CANOPY STRUCTURE AND PHOTOSYNTHETIC ACTIVITIES THROUGH GEDI DATA". The research will be conducted at Rutgers' facilities in New Brunswick, New Jersey. This grant is not a set-aside award....
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a firm-fixed-price purchase order contract to Rutgers, The State University in the amount of $16,820.23. The contract, which has a completion date of June 30, 2025, is for the provision of custom mouse model CRISPR gene editing services. Rutgers, a major public research institution and 1862 land grant university, will leverage its expertise in biomedical sciences and laboratory facilities to deliver these services to NINDS. This contract is not designated as a set-aside. Rutgers also holds an Indefinite Delivery Contract (IDC) with a $15 million ceiling value, awarded by the National Institute on Drug Abuse (NIDA), to operate the NIDA Center for Genetic Studies, which enables NIDA to advance research on genetic factors related to substance use disorders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.8k | 8/1/24 |